United States · FDA National Drug Code directory
Budesonide Inhalation Suspension
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76282-640_c53a81a4-fad8-4587-ac13-cc4de968485e
- Product NDC
- 76282-640
- Form
- INHALANT
- Composition / generic term
- Budesonide
- Labeler
- Exelan Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190417
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — .25 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 6 POUCH in 1 CARTON (76282-640-38) / 5 AMPULE in 1 POUCH (76282-640-37) / 2 mL in 1 AMPULE · 76282-640-38
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →